A Clinical Study of Disitamab Vedotin for Injection Combined With Penpulimab Injection in Neoadjuvant Therapy for Patients With HER2-expressing Cisplatin-intolerant cT2-T4aNxM0 Bladder Urothelial Carcinoma
Clinical trial NCT05488353 · UNKNOWN
Trial details
- NCT number
- NCT05488353
- Sponsor
- Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
- Status
- UNKNOWN
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2022-09-01
- Primary completion
- 2026-04-30
- Enrollment
- 48
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.